CD274 and non-small cell lung carcinoma: Nevertheless, the poor survival could also be because those patients were not treated with an ICI-based strategy, and larger prognostic trials are needed to assess the prognostic and predictive effects of PD-L1 expression in patients with OMD NSCLC.